Nanomedicine opportunities in cardiology (Q36667383)

15 August 2017

1 reference

title

Nanomedicine opportunities in cardiology (English)

1 reference

15 August 2017

1 reference

2

Patrick Winter

1 reference

15 August 2017

Gregory Lanza

1

1 reference

15 August 2017

Tillmann Cyrus

3

1 reference

15 August 2017

Shelton Caruthers

4

1 reference

15 August 2017

Jon Marsh

5

1 reference

15 August 2017

Michael Hughes

6

1 reference

15 August 2017

Samuel Wickline

7

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 October 2006

1 reference

Annals of the New York Academy of Sciences

15 August 2017

published in

1 reference

15 August 2017

volume

1080

1 reference

15 August 2017

page(s)

451-465

1 reference

Improved molecular imaging contrast agent for detection of human thrombus

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1380.034

In vitro demonstration using 19F magnetic resonance to augment molecular imaging with paramagnetic perfluorocarbon nanoparticles at 1.5 Tesla

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1380.034

Pathologic assessment of the vulnerable human coronary plaque

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1380.034

Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1380.034

Terminology for high-risk and vulnerable coronary artery plaques. Report of a meeting on the vulnerable plaque, June 17 and 18, 2003, Santorini, Greece

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1380.034

In vivo magnetic resonance imaging of coronary thrombosis using a fibrin-binding molecular magnetic resonance contrast agent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1380.034

In vivo molecular imaging of acute and subacute thrombosis using a fibrin-binding magnetic resonance imaging contrast agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1380.034

Controlling the vasculature: angiogenesis, anti-angiogenesis and vascular targeting of gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1380.034

Plaque angiogenesis: its functions and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1380.034

Structure of human methionine aminopeptidase-2 complexed with fumagillin

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1380.034

Sonic activation of molecularly-targeted nanoparticles accelerates transmembrane lipid delivery to cancer cells through contact-mediated mechanisms: implications for enhanced local drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1380.034

Novel paramagnetic contrast agents for molecular imaging and targeted drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1380.034

Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1380.034

MR portal venography: preliminary results of fast acquisition without contrast material or breath holding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1380.034

Sirolimus eluting stent implantation for patients with multivessel disease: rationale for the Arterial Revascularisation Therapies Study part II (ARTS II).

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1380.034

Rapamycin eluting stent: the onset of a new era in interventional cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1380.034

Late angiographic stent thrombosis (LAST) events with drug-eluting stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1380.034

Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1380.034

Coronary stent thrombosis in the current drug-eluting stent era: insights from the ERACI III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1380.034

Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1380.034

Comparative study of cyclosporine and tacrolimus vs newer immunosuppressants mycophenolate mofetil and rapamycin on coronary endothelial function

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1380.034

Sirolimus-eluting stents associated with paradoxic coronary vasoconstriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1380.034

MR three-dimensional molecular imaging of intramural biomarkers with targeted nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1380.034

Thrombolytic therapy in patients with acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1380.034

Tissue plasminogen activator for acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1380.034

Clinical and pharmacokinetic study of TNP-470, an angiogenesis inhibitor, in combination with paclitaxel and carboplatin in patients with solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1380.034

21 January 2018

Identifiers

DOI

10.1196/ANNALS.1380.034

1 reference

15 August 2017

1 reference